rs1554281016
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001277115.2(DNAH11):c.9815A>G(p.Asn3272Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000000684 in 1,461,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461502Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727016
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
DNAH11-related disorder Uncertain:1
The DNAH11 c.9815A>G variant is predicted to result in the amino acid substitution p.Asn3272Ser. This variant has been reported together with second DNAH11 variant in an individual with suspected Primary Ciliary Dyskinesia (Table 1, Staar et al. 2023. PubMed ID: 37998386). This variant has not bee reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Primary ciliary dyskinesia Uncertain:1
This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with serine at codon 3272 of the DNAH11 protein (p.Asn3272Ser). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and serine. This variant has not been reported in the literature in individuals with DNAH11-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at